Posted by: admin Categories: Genetics

The first clinical trials of CRISPR are being run right now by CRISPR Therapeutics (Nasdaq: CRSP) and Editas Medicine (Nasdaq: EDIT). Those of ...

Source link

« Effects of Electroporation Treatment Using Different Concentrations of Cas9 Protein With gRNA Targeting Myostatin (MSTN) Genes on the Development and Gene Editing of Porcine Zygotes

Market Size, Trends, Scope & Challenges To 2026 – 3w Market News Reports »

Latest Tweets

Registration and all functionalities at breathinglabs.com (and in our iOS and Android games) are fixed and fu… twitter.com/i/web/status/12407…
March 19, 2020 10:50 pm
Registration on breathinglabs.com (+ in android/ios games) is not working atm and your serials will show as i… twitter.com/i/web/status/12333…
February 28, 2020 8:04 am
We are back in stock with Breathing+, currently searching for VR supplier, and setting up mass production for toys… twitter.com/i/web/status/11717…
September 11, 2019 12:00 pm
BREAKING: Nintendo Co. Ltd (Japan) is implementing Breathing Games by @breathinglabs in FDA approved clinical trial… twitter.com/i/web/status/11580…
August 4, 2019 5:55 pm
Notice to b2b partners: we are running late with some minor upgrade-> briefly running out of stock -> retail and b2… twitter.com/i/web/status/11337…
May 29, 2019 1:48 pm
BREAKING: Our product BREATHING+ shows significant and reliable diagnostic value in comparison to standard spiromet… twitter.com/i/web/status/10812…
January 4, 2019 4:02 pm
Video: Resperate company endorses pursed lip breathing and shows pulmonary function improvement in real time.… twitter.com/i/web/status/10711…
December 7, 2018 8:51 pm
Notice on limited availability during July 25th and August 5th: Help and support will be mostly functional via supp… twitter.com/i/web/status/10148…
July 5, 2018 1:41 pm
We are migrating to safer servers @Cloudflare, our pages will be back in 48hrs. We are available on email [email protected]… twitter.com/i/web/status/97947…
March 29, 2018 9:50 pm

Home

How To Start

Q&A

Login

Startup aiming to end heart disease with 'gene-editing for the masses' raises $63M

Latest Tweets

ABOUT

TECHNOLOGY

CLINICAL USE

COLLABORATION

REFERENCE

Home

How To Start

Products

Breathing+ Package

Toys Package

Q&A

Login

Startup aiming to end heart disease with 'gene-editing for the masses' raises $63M

You may also like...

CRISPR Therapeutics AG (NASDAQ:CRSP) Share Price Tumble Recently, But Trouble May Still Be Afoot

Transforming MEGAN output with Krona

CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know

Latest Tweets

ABOUT

TECHNOLOGY

CLINICAL USE

COLLABORATION

REFERENCE